Cargando…

ODP124 Sickle Cell Bone Disease and Response to Intravenous Bisphosphonates in Children

PURPOSE: To evaluate bone morbidity and the response to intravenous (IV) bisphosphonate therapy in children with Sickle Cell Disease (SCD). METHODS: We conducted a retrospective review of patient records from 2003 to 2019 at three Canadian pediatric tertiary care centers. Radiographs, magnetic reson...

Descripción completa

Detalles Bibliográficos
Autores principales:	Todd Alexander, R, Grimbly, Chelsey, Ward, Leanne M, Escagedo, Patricia Diaz, Jaremko, Jacob L, Bruce, Aisha, Alos, Nathalie, Robinson, Marie-Eve, Konji, Victor N, Page, Marika, Simpson, Ewurabena, Pastore, Yves D, Girgis, Rose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Bone & Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624790/ http://dx.doi.org/10.1210/jendso/bvac150.365

Ejemplares similares

Sickle cell bone disease and response to intravenous bisphosphonates in children
por: Grimbly, C., et al.
Publicado: (2022)

ODP232 Postoperative Glycemic Management of Children Undergoing Pancreatectomy with Islet Autotransplantation
por: Grimbly, Chelsey, et al.
Publicado: (2022)

ODP080 Bisphosphonate treatment for osteoporosis in children with Gorham-Stout syndrome: a case report
por: Ahn, Moon Bae, et al.
Publicado: (2022)

ODP112 Post-infusion ECG Changes in Patients Receiving Intravenous Bisphosphonates: a Systematic Review and Meta-Analysis
por: Shoung, Alex, et al.
Publicado: (2022)

ODP081 Bisphosphonates: To Give or Not to Give, that is the Question – A case of prolonged hypercalcemia in a patient with severe rhabdomyolysis complicated by bilateral foot drop
por: Musurakis, Clio, et al.
Publicado: (2022)

ODP093 Hunt for Hypercalcemia
por: Wang, Ally W, et al.
Publicado: (2022)

ODP115 Primary Hyperparathyroidism in Pregnancy
por: Rosado-Burgos, Alexandra, et al.
Publicado: (2022)

ODP071 A Fit of Hypophosphatemia
por: Naha, Sowjanya, et al.
Publicado: (2022)

ODP131 Zoledronic acid and red eye
por: Patel, Urja, et al.
Publicado: (2022)

ODP085 Denosumab Induced Severe Hypophosphatemia
por: Del Mar Morales Hernandez, Maria, et al.
Publicado: (2022)

ODP592 Delay in Diagnosis of Adult with Familial Hypophosphatasia
por: Choe, Chlarles, et al.
Publicado: (2022)

ODP078 An Unsolved Mystery of Hyperparathyroidism for 12 Years
por: Pant, Nicole, et al.
Publicado: (2022)

ODP589 Acute Hypercalcemic Crisis in an Elderly with Granulomatous Disease
por: Capellan, Maria Leonora, et al.
Publicado: (2022)

ODP068 A Case Report of Nivolumab Associated Hypercalcemia
por: Sherpa, Chheki, et al.
Publicado: (2022)

ODP099 Hyperparathyroidism Causing life Threatening Hypercalcaemia in Pregnancy
por: Lee, Jessica, et al.
Publicado: (2022)

ODP086 Detecting Primary Hyperparathyroidism with Image Discordant Findings
por: Nikjoo, Arya, et al.
Publicado: (2022)

ODP134 Resistant Hypocalcemia in prostate cancer with osteoblastic metastasis
por: Hariharan, Vikaash, et al.
Publicado: (2022)

ODP075 A Rare Case of Intrathymic Parathyroid Adenoma
por: Heluey, Camila, et al.
Publicado: (2022)

ODP595 Case Series Of Idiopathic Hypercalciuria And Secondary Osteoporosis
por: Mirza, Fayal, et al.
Publicado: (2022)

ODP588 A Rare Case Of Infantile Transient Psuedohypoparathyrodism
por: Hathi, Deep, et al.
Publicado: (2022)

ODP117 Pseudohypoparathyroidism Type IB: A Rare Cause of Hypocalcemia
por: Encarnacion, Dionardo Medina, et al.
Publicado: (2022)

ODP121 Recurrent atypical parathyroid adenoma: a case report
por: Siqueira, Hiloma, et al.
Publicado: (2022)

ODP116 Proton Pump Inhibitor Induced Hypocalcemia - An Overlooked Cause
por: Rivera, Krystal, et al.
Publicado: (2022)

ODP100 Hypoparathyroidism in the Setting of COVID-19: Increasingly Common Phenomenon
por: Markov, Alexander, et al.
Publicado: (2022)

ODP104 Isolated familial hypoparathyroidism with Tbx1 mutation in Korea
por: Lee, Seunghyun, et al.
Publicado: (2022)

ODP095 HYPERCALCEMIA FROM SILICONE BUTTOCK INJECTION INDUCED GRANULOMA.
por: Chin, Edward, et al.
Publicado: (2022)

ODP098 Hyperparathyroidism Caused by Two Large Water Clear Cell Adenomas
por: Ali, Rafal, et al.
Publicado: (2022)

ODP102 Indicators for the effects of calcimimetics on hypercalcemia in the elderly patients with primary hyperparathyroidism.
por: Yamamoto, Koichro, et al.
Publicado: (2022)

ODP076 A Unique Case of Iatrogenic Hypermagnesemia Induced Symptomatic Hypocalcemia
por: Singles, Andrew, et al.
Publicado: (2022)

ODP091 Giant Parathyroid Adenoma Presenting with Pseudoclubbing - A Case Report
por: Deb, Prasun, et al.
Publicado: (2022)

ODP090 Fragility Fractures and Osteoporosis Screening in Patients with Chronic Lymphocytic Leukemia
por: Petty, Lloyd, et al.
Publicado: (2022)

SAT-540 Bisphosphonates and Fracture Incidence in Young Adults
por: Choudhary, Manita, et al.
Publicado: (2019)

SAT-502 Bisphosphonates for Treatment of Calcitriol-Induced Hypercalcemia
por: Mateo, Roselyn Cristelle, et al.
Publicado: (2019)

MON-LB67 Bisphosphonate Related Ocular Inflammation
por: Seetharaman, Kavita
Publicado: (2020)

Metaphyseal and posterior rib fractures in osteogenesis imperfecta: Case report and review of the literature
por: Bobyn, Amy, et al.
Publicado: (2022)

ODP113 Presentation of two similar Klinefelter Syndrome cases with different clinical outcomes
por: Marenych, Nadiia, et al.
Publicado: (2022)

ODP094 Hypercalcemia caused by Mycobacterium Avium Complex, with Excellent Response to Intravenous Pamidronate.
por: Khthir, Rodhan
Publicado: (2022)

ODP110 Parathyroid Hormone Independent Hypercalcaemia Secondary to Granulomatous Inflammation: Could This Be Melioidosis?
por: Grace, Samuel, et al.
Publicado: (2022)

ODP125 Soft Bones in Crohn's: Tumor-induced osteomalacia and inflammatory bowel disease
por: Habbsa, Samima, et al.
Publicado: (2022)

ODP107 Oral Ulcerations, A Rare Side Effect of Intravenous Zoledronic Acid
por: Del Mar Morales Hernandez, Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qu2fc466hjqiqhpa9h0m2r5bqc